Foreign Property News | Posted by Shwe Zin Win
An experimental coronavirus vaccine developed by Chinese state-owned pharmaceutical giant Sinopharm has 86% efficacy, the United Arab Emirates Health Ministry said in a statement Wednesday.
The Health Ministry said the results for the vaccine were based on interim analysis of the late-stage clinical trials which the UAE started in July, according to the statement which was carried by the state news agency.
Though few details were provided, the statement marks the first publicly released information regarding the performance of the Chinese vaccine, developed by the China National Biotec Group (CNBG), a unit of Sinopharm. The UAE approved emergency use for frontline workers in September.
"The analysis shows no serious safety concerns," the statement said, though it did not make clear whether individual participants suffered any specific side effects, or how many volunteers were given the vaccine or a placebo.
The statement added that the "official registration" of the Covid-19 vaccine is "a major step towards combating the global pandemic." The statement did not elaborate on what official registration would entail.
The clinical trials included 31,000 volunteers across 125 nationalities in the UAE, the statement said. So far, almost 100,000 people across the Emirates have also received the vaccine as part of a voluntary program, Jamal Al Kaabi, a top UAE health official told CNN.
UAE Vice President and Prime Minister Sheikh Mohammed bin Rashid Al Maktoum was pictured receiving the jab during trials in November.
China currently has five coronavirus candidates from four companies which have reached phase 3 clinical trials, the last and most important step of testing before regulatory approval is sought.
Having largely eliminated the spread of coronavirus inside its borders, Chinese drugmakers had to look abroad for places to test the efficacy of their vaccines. Together, they have rolled out phase 3 trials in at least 16 countries.
Ref: CNN
